chartexchange

CGTX
Cognition Therapeutics, Inc. Common Stock
stockNASDAQ

Market OpenOct 5, 2026 10:47:07 AM EDT
0.93USD+0.065%(+0.00)60,130
0.8000Bid1.1100Ask0.3100Spread
Pre-marketOct 5, 2026 9:13:30 AM EDT
0.9255USD+0.043%(+0.0004)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Purchase, NY, USA
Previous Close
$0.93
Beta
2.61
52-Week High
$2.05 2025-10-10
52-Week Low
$0.55 2026-03-30
SMA 50
$0.99
SMA 200
$1.13
Avg. Vol 10D
468,071
Avg. Vol 30D
399,593
Avg. Vol 90D
1.06M
Relative Vol
0.14
81.83M
0.5100%
2,700,000
406
Nov 5, 2026 (31d)
CGTX Profile

cognition therapeutics inc. is a drug discovery and development company located in pittsburgh, pennsylvania. founded in 2007, the company uses proprietary biology and chemistry platforms to discover novel drug targets and disease modifying therapies for disorders of the central nervous system.

CGTX Performance
PeriodPriceDateChangeBeta
1W0.942026-09-28-0.63%2.123
1M1.032026-09-04-9.47%0.289
3M1.072026-07-06-12.85%1.411
6M0.842026-04-06+11.32%1.562
1Y1.542025-10-06-39.45%2.607
2Y0.442024-10-04+114.37%—
5Y12.772021-10-08-92.70%1.363
CGTX Stock Summary

Cognition Therapeutics, Inc. Common Stock (NASDAQ:CGTX) stock price today is $0.93, and today's volume is 55,061. CGTX is up 0.800% today. The 30 day average volume is 399,593. CGTX market cap is $88.67M with 95.09M shares outstanding.